Molecular Formula | C10H12N4NaO5S |
Molar Mass | 323.28 |
Melting Point | 140-147°C |
Boling Point | 77℃ |
Specific Rotation(α) | α]/D 144±4°, c = 0.1 in H2O |
Flash Point | >110°(230°F) |
Water Solubility | Soluble in water.Soluble in water and methanol. |
Solubility | H2O: 50 mg/mL, clear, colorless |
Appearance | White powder |
Color | white |
Storage Condition | Keep in dark place,Inert atmosphere,2-8°C |
Stability | Hygroscopic |
MDL | MFCD00917472 |
Use | Is an irreversible competitive β-lactamase inhibitor |
Hazard Symbols | Xi - Irritant |
Risk Codes | 36/37/38 - Irritating to eyes, respiratory system and skin. |
Safety Description | S22 - Do not breathe dust. S24/25 - Avoid contact with skin and eyes. S36 - Wear suitable protective clothing. S26 - In case of contact with eyes, rinse immediately with plenty of water and seek medical advice. |
WGK Germany | 3 |
RTECS | XI0191500 |
Tazobactam sodiumsalt: Cio HU N4NaoS.CAS accession number [89785-84-2]. Amorphous solid, melting point> 170 °c (decomposition). Soluble in water, slightly soluble in methanol, ethanol, insoluble in acetone, ethyl acetate, ether.
with sulbactam as raw material, the carboxyl group was protected by alcoholization, and then reacted with sodium azide to introduce an azide group on the methyl group. Reaction with vinyl acetate to form a triazole compound, and finally the hydrogen is freed from the protecting group to give tazobactam. Alternatively, 6-APA (6-aminopenicillanic acid) is used as a raw material, which is subjected to diazotization, bromination, peracetic acid oxidation, and then alcoholization, and then debromination is carried out under the action of zinc. It is then reacted with the trimethylsilyltriazole compound, the triazole compound is introduced, the potassium permanganate is oxidized, and finally the sodium tazobactam is hydrolyzed.
Japan Dapeng (Taiho) company research and development. p-lactamase inhibitors. For clinically important beta-lactamases such as penicillinase produced by S. Aureus, Proteus, Bacteroides, the chromosome-mediated p-lactamases produced by Klebsiella pneumoniae have a strong inhibitory effect. The width of the enzyme spectrum and the intensity of inhibition of enzyme activity were better than those of clavulanic acid and sulbactam. Its low toxicity, good stability, strong inhibition of enzyme activity. For the treatment of a variety of bacteria including aerobic and anaerobic bacteria caused by infection, including lower respiratory tract infections, skin and abdominal infections.